Suchergebnisse - "Combined Modality Therapy"

PubPharm (27)

1

A new strategy for immunotherapy of microsatellite-stable (MSS)-type advanced colorectal cancer : Multi-pathway combination therapy with PD-1/PD-L1 inhibitors

enthalten in: Immunology | 2024

von Cai, L. | Chen, A. | Tang, D.

2

Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity

enthalten in: Journal for immunotherapy of cancer | 2023

von Fernandez-Rodriguez, L. | Cianciaruso, C. | Bill, R. | +16

ErratumIn: J Immunother Cancer. 2023 Jul;11(7):. - PMID 37460252

3

BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells

enthalten in: Journal for immunotherapy of cancer | 2023

von van Helden, M. | Zwarthoff, S. | Arends, R. | +30

4

Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)

enthalten in: Journal for immunotherapy of cancer | 2022

von Vavolizza, R. | Petroni, G. | Mauldin, I. | +10

ErratumIn: J Immunother Cancer. 2022 Nov;10(11):. - PMID 36332930

5

Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors

enthalten in: Journal for immunotherapy of cancer | 2022

von Sanborn, R. | Pishvaian, M. | Callahan, M. | +21

6

Systemic effect of radiotherapy before or after nivolumab in lung cancer : an observational, retrospective, multicenter study

enthalten in: Tumori | 2022

von Bassanelli, M. | Ricciuti, B. | Giannarelli, D. | +13

7

Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies

enthalten in: Journal for immunotherapy of cancer | 2022

von Minnar, C. | Chariou, P. | Horn, L. | +4

8

Durable response to durvalumab-based immunochemotherapy in small-cell lung carcinoma transformation from EGFR-mutant non-small cell lung cancer : A case report

enthalten in: Thoracic cancer | 2022

von Li, Y.

9

System analysis based on the cancer-immunity cycle identifies ZNF207 as a novel immunotherapy target for hepatocellular carcinoma

enthalten in: Journal for immunotherapy of cancer | 2022

von Wang, X. | Zhou, T. | Chen, X. | +7

10

Immunotherapy combining tumor and endothelium cell lysis with immune enforcement by recombinant MIP-3α Newcastle disease virus in a vessel-targeting liposome enhances antitumor immunity

enthalten in: Journal for immunotherapy of cancer | 2022

von Wang, J. | Chen, H. | Dai, S. | +6